Li et al found that SNHG1 not only promoted pancreatic cancer tumorigenesis, but also was differently expressed in gemcitabine‐resistant and gemcitabine‐sensitive pancreatic cells, which suggested that SNHG1 could play an important role in tumor therapy. This evidence concerns the gene SNHG1 and neoplasm.